Bioimpedance Analysis for Follow-up of Dieters

NCT02975427 | Completed

• 1 other identifier: KA12/192
• Study Type: observational
• Target: 103
• Locations: 0 countries
• Sites: N/A

Brief Summary

Prospective, single arm, dietary intervention study.

Conditions

Obesity

Keywords

Diet; Abdominal bioelectrical impedance analysis; Anthropometry; Insulin resistance

Outcome Measures

Primary Outcomes (1)

• Value of abdominal BIA for the follow up of dieting individual

  3 months (plus or minus 1 month)

Study Arms (1)

Diet group

All participants were prescribed an appropriate diet with caloric restriction and an exercise program and underwent a follow-up examination 3±1 months later.

Other: Diet group

Interventions

Diet group OTHER

All participants were prescribed an appropriate diet with caloric restriction and an exercise program and underwent a follow-up examination 3±1 months later.

Diet group

Eligibility Criteria

• Age: 18 Years - 70 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

One hundred and eighty five participants who were admitted to hospital for weight loss therapy enrolled to the study. After initial evaluation, all participants were prescribed an appropriate diet with caloric restriction and an exercise program and underwent a follow-up examination 3±1 months later. A total of 134 participants reported for the second visit; 51 did not. Thirty one participants who, at the second visit, reported that they failed to adhere to the diet were excluded from the analysis . Ultimately, data from 103 participants who reported that they adhered to the diet were included in the analysis.

You may qualify if:

• Participants aged 18 to 70 years without chronic disease, cancer, a pacemaker, cardiac valve replacement, malabsorption syndrome, previous history of gastrointestinal surgery, thyroid disease, pregnancy, or a history of surgery during the previous 3 months.

You may not qualify if:

• Participants receiving oral antidiabetic drugs, insulin, any treatment for obesity, steroids or hormonal drugs, over-the-counter drugs for weight loss, any kind of phytodrug, or any drug that could affect glucose metabolism. We also excluded patients who used any of these drugs after the initial evaluation.
• Participants who, at the second visit, reported that they failed to adhere to the diet.

Sponsors & Collaborators

• Baskent University Ankara Hospital: lead

MeSH Terms

Conditions

Obesity; Insulin Resistance

Condition Hierarchy (Ancestors)

Overweight; Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Hyperinsulinism; Glucose Metabolism Disorders; Metabolic Diseases

Study Officials

• Yusuf Bozkuş, Dr.

  Baskent University Ankara Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr.

Study Record Dates

• First Submitted: October 27, 2016
• First Posted: November 29, 2016
• Study Start: December 1, 2011
• Primary Completion: June 1, 2013
• Study Completion: March 1, 2014
• Last Updated: November 29, 2016

Record last verified: 2016-11

Data Sharing

• IPD Sharing: Will not share